Clinical Trial Update: Treatment Strategy for Relapsed/Refractory Hodgkin Lymphoma [Phase 2, Phase 3]

View source ↗

Summary

Ongoing Phase 2/Phase 3 clinical trial for relapsed/refractory Hodgkin lymphoma, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: Hospital Regional de Alta Especialidad del Bajio | Conditions: Hodgkin Lymphoma, Refractory Hodgkin Lymphoma | Phase 2, Phase 3 | Status: RECRUITING